SREBF1 and Hepatic steatosis: Some data have showed that decreased expression of hepatic FXR is associated with an increased expression of SREBP-1C, LXR, and hepatic triglyceride synthesis; furthermore, increased SREBP-1C is associated with the degree of hepatic steatosis in the NAFLD patients [32].